SLP Simulations Plus Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SLP

Price (delayed)

$18.42

Market cap

$372.54M

P/E Ratio

46.05

Dividend/share

N/A

EPS

$0.4

Enterprise value

$337.7M

?
Relative Growth: Rel. Growth: 57
Relative Strength: Rel. Strength: 71
Relative Valuation: Rel. Valuation: 48
Relative Profitability: Rel. Profitability: 85

With more than 25 years of experience serving clients globally, Simulations Plus stands as a premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug ...

Highlights
The net income has soared by 113% since the previous quarter and by 113% year-on-year
The company's EPS has surged by 113% QoQ and by 113% YoY
Sector: Healthcare
Industry: Health Information Services
Website: http://www.simulations-plus.com
Peers: SMSI

Key stats

What are the main financial stats of SLP

SLP stock price

How has the Simulations Plus stock price performed over time
Intraday
-0.05%
1 week
0%
1 month
0.6%
1 year
28.09%
YTD
1.04%
QTD
0.6%

Financial performance

How have Simulations Plus's revenue and profit performed over time
Revenue
$82.06M
Gross profit
$52.01M
Operating income
$11.5M
Net income
$8.11M
Gross margin
63.4%
Net margin
9.9%
The operating margin has surged by 117% since the previous quarter and by 116% year-on-year
The operating income has surged by 117% since the previous quarter and by 116% year-on-year
The net income has soared by 113% since the previous quarter and by 113% year-on-year
The net margin has soared by 113% from the previous quarter and by 113% YoY

Price vs fundamentals

How does SLP's price correlate with its fundamentals

Growth

What is Simulations Plus's growth rate over time

Valuation

What is Simulations Plus stock price valuation
SLP P/E details
P/E
46.05
P/B
2.68
P/S
4.54
EV/EBIT
26.91
EV/EBITDA
18.59
EV/Sales
4.12
The company's EPS has surged by 113% QoQ and by 113% YoY
The price to book (P/B) is 38% lower than the 5-year quarterly average of 4.3 but 17% higher than the last 4 quarters average of 2.3
SLP's equity is up by 12% year-on-year and by 3.9% since the previous quarter
The price to sales (P/S) is 62% less than the 5-year quarterly average of 11.9 but 19% more than the last 4 quarters average of 3.8
SLP's revenue is up by 2.1% YoY

Efficiency

How efficient is Simulations Plus business performance
The company's return on sales has surged by 119% QoQ and by 118% YoY
Simulations Plus's return on invested capital has surged by 118% QoQ and by 116% YoY
SLP's ROE has soared by 117% YoY and by 113% QoQ
The company's return on assets has surged by 116% YoY and by 113% QoQ

Dividends

What is SLP's dividend history
Dividend details
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Simulations Plus financials performed over time
The total liabilities is up by 32% year-on-year and by 10% since the previous quarter
The quick ratio has grown by 16% YoY
The debt is 100% less than the equity
The debt to equity has dropped by 100% year-on-year
The debt has contracted by 32% YoY and by 4.1% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.